BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3133667)

  • 1. Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice.
    Montemurro P; Coluccia M; De Nicolò L; Colucci M; Semeraro N
    Pharmacol Res Commun; 1988 Apr; 20(4):255-64. PubMed ID: 3133667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
    Colucci M; Paramo JA; Collen D
    J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus.
    Krishnamurti C; Wahl LM; Alving BM
    Am J Trop Med Hyg; 1989 Jan; 40(1):102-7. PubMed ID: 2492775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation.
    Helin HJ; Edgington TS
    J Immunol; 1984 Mar; 132(3):1074-6. PubMed ID: 6229574
    [No Abstract]   [Full Text] [Related]  

  • 5. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of procoagulant and plasminogen activator activities among density fractions of normal rabbit alveolar macrophages.
    Sitrin RG; Brubaker PG; Shellito JE; Kaltreider HB
    Am Rev Respir Dis; 1986 Mar; 133(3):468-72. PubMed ID: 3954254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
    Wohlwend A; Belin D; Vassalli JD
    J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant activity of peritoneal leukocytes: effects of cortisone and endotoxin.
    Robinson AJ; Rapaport SI; Brown SF
    Am J Physiol; 1978 Sep; 235(3):H333-7. PubMed ID: 696844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Chapman HA; Vavrin Z; Hibbs JB
    Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of macrophage procoagulant and fibrinolytic activities induced by peritoneal dialysis solutions.
    Freyria AM; Paul J; Belleville J; Rissoan MC; Fuselier M; Eloy R
    J Lab Clin Med; 1991 Mar; 117(3):194-201. PubMed ID: 2002276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
    Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
    J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
    Sprengers ED; Akkerman JW; Jansen BG
    Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: a possible mechanism of antithrombotic action.
    Hasday JD; Sitrin RG
    Blood; 1987 Feb; 69(2):660-7. PubMed ID: 3801675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.
    Crutchley DJ; McPhee GV; Terris MF; Canossa-Terris MA
    Arteriosclerosis; 1989; 9(6):934-9. PubMed ID: 2511826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
    Krishnamurti C; Alving B
    Rev Infect Dis; 1989; 11 Suppl 4():S843-6. PubMed ID: 2501855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation.
    Virji MA; Aggarwal S; Kang Y
    Transplant Proc; 1989 Jun; 21(3):3540-1. PubMed ID: 2500760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].
    Jia HY; Chen HZ; Pu SY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug; 16(4):214-6, 254. PubMed ID: 3147887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.